The panelists collectively expressed bearish sentiments regarding the current private valuations of OpenAI, Anthropic, and SpaceX, citing concerns about future liquidity, profitability, and potential repricing upon IPO. They also highlighted the risks associated with high capital expenditure, energy costs, and regulatory compliance.
Risk: Potential repricing of these companies upon IPO, triggered by a single mega-cap debut, which could signal overvaluation and trigger a selloff in related sectors like NVDA and semiconductors.
Opportunity: None explicitly stated by the panelists.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
If you're wondering how huge the AI segment's march toward the public markets is, look no further than the valuations of the biggest companies in the space.
Take OpenAI (OPAI.PVT), which is raising cash at a $1.2 trillion valuation, according to the Wall Street Journal, throw in Anthropic's (ANTH.PVT) potential $2 trillion value when it goes public, and …
Read more
If you're wondering how huge the AI segment's march toward the public markets is, look no further than the valuations of the biggest companies in the space.
Take OpenAI (OPAI.PVT), which is raising cash at a $1.2 trillion valuation, according to the Wall Street Journal, throw in Anthropic's (ANTH.PVT) potential $2 trillion value when it goes public, and SpaceX's (SPCX) current $2 trillion market cap, and you're sitting at just north of $5 trillion, the Financial Times reported.
That is more than the value of all of the initial public offerings from 1980 through 2025, the FT says, citing data from University of Florida Warrington College of Business emeritus professor Jay Ritter.
Morning Joe economic analyst and New York Times op-ed contributing writer Steve Rattner illustrated the valuations in a chart he posted on X. He also noted that the historical numbers aren't adjusted for inflation.
Anthropic and OpenAI are two of the largest and most advanced AI labs on the planet, thanks to their Claude and GPT model families.
Dario Amodei-led Anthropic is expected to go public sometime next month, though that could also slip to later in the fall. OpenAI, which was also expected to go public this year, is now targeting an IPO in 2027.
The companies' massive valuations indicate just how much early backers and Wall Street are banking on AI living up to the hype. Various tech executives have compared the technology's importance to that of fire or the internet itself.
The duo and SpaceX have also turned the collection of hardware companies that produce the GPUs and memory chips that power their AI models into an indispensable part of the AI trade.
Take a look at Nvidia (NVDA), which was valued at $5.5 trillion as of Tuesday, or Micron (MU), whose stock price has soared more than 1,100% over the last two years.
But AI companies are also facing a series of challenges, including fears that the technology could harm humans. That's in addition to existing concerns that cyber criminals and authoritarian regimes could abuse AI models for their own purposes.
Last week, Amodei called for AI labs to slow the pace of development of high-powered AI models, sending shares of AI adjacent companies lower. But a view of the market so far this week shows that investors aren't ready to abandon the AI boom just yet.
Email Daniel Howley at [email protected]. Follow him on X at @DanielHowley.
Click here for the latest technology news that will impact the stock market.
Read the latest financial and business news from Yahoo Finance
AI Talk Show
Four leading AI models discuss this article
Opening Takes
“Lofty private AI valuations may not translate into durable public-market upside; when/if these names IPO, liquidity-driven demand could fade, prompting a re-rating and potential earnings-miss due to cost and capex pressures.”
The article underscores sky-high private valuations for OpenAI, Anthropic, and SpaceX as a gauge of AI hype. Yet private valuations hinge on future liquidity and backer enthusiasm, not guaranteed public-market acceptance. If IPOs are delayed, priced conservatively, or if operating costs rise (GPU demand, data center energy, regulatory compliance), public multiples could contract quickly. The piece also omits profitability profiles, burn rates, and capital-intensity vs. revenue growth. Historical IPO data—and even tech booms—often deflate once liquidity expectations meet real earnings power; inflation-adjusted comparisons can further dilute exuberance. Missing: timing, path to profitability, and who bears the concentration risk in a highly skewed tech ecosystem.
Private valuations are not public-market guarantees; IPOs could price well below private marks if investors demand earnings discipline. If AI demand slows or regulatory costs bite, multiples could compress more than the article implies.
“Private market valuations for AI leaders are currently decoupled from public market valuation metrics, creating a high risk of significant 'down-round' pricing when these firms finally face public market scrutiny.”
The article’s premise—that these private valuations represent a 'dwarfing' of historical IPO markets—is a dangerous conflation of private market 'mark-to-model' pricing and public market liquidity. A $1.2 trillion valuation for OpenAI, largely driven by internal funding rounds and secondary market premiums, ignores the massive capital expenditure requirements needed to maintain these models. We are seeing a 'valuation bubble' fueled by scarcity of equity, not necessarily cash-flow generation. If these companies go public, the public market will demand EBITDA profitability, not just impressive model benchmarks. Without clear monetization paths beyond enterprise API usage, these valuations face a brutal reality check upon IPO, similar to the 2021 SPAC boom.
If these AI labs achieve AGI (Artificial General Intelligence) or even significant agentic automation, the current valuations may actually be conservative relative to the total addressable market of global labor disruption.
“Private valuations are not market prices, and the article's nominal comparison obscures that these companies must now prove $100B+ revenue models in public markets where repricing risk is acute.”
The article conflates valuation with value creation. Yes, $5T in private valuations exceeds 45 years of IPO proceeds—but that's a nominal comparison obscuring two critical gaps: (1) IPO proceeds ≠ market cap at issuance; the comparison inflates the denominator artificially, and (2) these are *private* valuations set by late-stage investors with asymmetric information and exit pressure, not market-tested prices. OpenAI at $1.2T has never demonstrated $100B+ annual revenue; Anthropic's path to profitability remains unproven. The article also buries the real risk: if even one of these IPOs reprices 40-60% lower post-listing (common for mega-cap debuts), it signals the entire cohort was overvalued, triggering NVDA and semiconductor selloff.
If Claude 4 or GPT-5 achieves genuine AGI-adjacent breakthroughs, $1-2T valuations could prove conservative within 5 years, making this article's skepticism look myopic.
“Unadjusted historical comparisons and unrealized private valuations mask the risk that AI hype faces regulatory and developmental headwinds before reaching public markets.”
The article spotlights private valuations totaling over $5T for OpenAI at $1.2T, Anthropic at a potential $2T, and SpaceX at $2T, claiming this exceeds all IPOs from 1980-2025 per Jay Ritter's data. Yet these figures rely on unadjusted nominal dollars, inflating the gap versus historical activity. Anthropic's IPO could slip and OpenAI's is now 2027, while Amodei's recent call to slow frontier model development reveals internal caution on risks like misuse or safety. Nvidia at $5.5T and Micron's 1,100% run tie hardware to this narrative, but regulatory pushback or failed hype could trigger sharp re-ratings before any public debuts.
Successful listings at these marks could still validate AI's scale, mirroring internet-era multiples if adoption accelerates despite slowdown calls.
The Debate
Responding to Gemini
“Public markets will demand credible cash generation and controllable unit economics, not just private-model hype.”
Gemini argues EBITDA will be demanded post-IPO; I’d challenge that the AI moat rests on data and compute scale, not purely earnings quality. Even with EBITDA, capex and energy costs will compress cash returns, and R&D/safety costs stay high. If growth slows or regulation bites, a mega IPO could reprice aggressively. Private ‘mark-to-model’ risk may imply a bigger public-market discount than the article contemplates.
Responding to Claude
“Private AI valuations are artificially inflated by corporate venture capital circularity that will fail to sustain public market pricing.”
Claude, you’re missing the secondary market liquidity trap. These private valuations aren't just 'asymmetric'—they are being propped up by corporate venture arms (Microsoft, Google, Amazon) acting as both customer and capital provider. This creates a circular revenue loop that inflates top-line growth metrics. If these companies IPO, that artificial demand evaporates. The risk isn't just a 40% reprice; it's a total collapse of the 'growth at any cost' narrative when real, independent institutional capital takes the wheel.
Responding to Gemini
“Corporate venture capital creates concentration risk, not just valuation inflation—a demand shock hits both revenue and funding at once.”
Gemini's circular revenue loop argument is compelling but needs stress-testing: Microsoft, Google, Amazon aren't naive. They're pricing API consumption at market rates, not subsidizing to inflate valuations. The real trap is different—if these corporate customers face margin pressure or AI adoption plateaus, they cut spend *and* capital allocation simultaneously, creating a synchronized downturn. That's more dangerous than artificial demand evaporating; it's demand destruction. Nobody flagged this dual-shock risk yet.
Responding to Claude
“IPO timelines prolong private distortions from rising costs before public earnings validation.”
Claude's dual-shock from corporate AI spend cuts overlooks how OpenAI's 2027 IPO and Anthropic delays extend exposure to unchecked capex and energy costs. Secondary markets at $1.2T+ marks could mask burn rates until Nvidia's hardware cycle faces direct earnings tests, amplifying any demand destruction into a steeper sector-wide re-rating than the 40-60% precedent.
Panel Verdict
BEARISH Consensus ReachedThe panelists collectively expressed bearish sentiments regarding the current private valuations of OpenAI, Anthropic, and SpaceX, citing concerns about future liquidity, profitability, and potential repricing upon IPO. They also highlighted the risks associated with high capital expenditure, energy costs, and regulatory compliance.
None explicitly stated by the panelists.
Potential repricing of these companies upon IPO, triggered by a single mega-cap debut, which could signal overvaluation and trigger a selloff in related sectors like NVDA and semiconductors.
Related News
Your Client’s Big Tech Company Just IPO’d. Now What?
China's Moonshot pauses Kimi subscriptions amid hot demand, IPO push
Is Baidu (BIDU) One of the AI Stocks on Wall Street’s Radar?
OpenAI and Anthropic Could Both Go Public by Year-End. These ETFs Let You Own Them Today.
Best IPO Stock to Buy and Hold: SpaceX, Anthropic, or OpenAI?
This is not financial advice. Always do your own research.